MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Utility of using long-read whole genome sequencing to solve exome negative early-onset and familial Parkinson’s disease: a series of 106 individuals

    G. Cogan, K. Bilingsley, K. Daida, C. Tesson, T. Courtin, M. Ferrien, A. Singleton, S. Lesage, C. Blauwendraat, A. Brice (Paris, France)

    Objective: (i) To identify complex variants usually not visible by short-read whole exome sequencing in known genes of Parkinson’s disease (PD) such as structural variants…
  • 2024 International Congress

    Clinical And Genetic Analysis Of Patients With Parkinson’s Disease -LRRK2 Variants From A Referral Centre In India

    S. Rath, PK. Pal, R. Yadav, VV. Holla, N. Kamble (MUMBAI, India)

    Objective: Our study aims to describe the clinical features and genetic profile of patients of PD carrying LRRK2 variants and draw correlation with genetic variants.…
  • 2024 International Congress

    Readiness for genetic testing among Indian movement disorder patients:A tertiary centre experience

    S. Kamath, V. Holla, N. Kamble, R. Mahale, R. Yadav, P. Pal (Bangalore, India)

    Objective: To assess knowledge & attitude of Indian patients with movement disorders and their caregivers to understand their readiness for genetic testing. Background: Genetic testing…
  • 2024 International Congress

    GBA Mutation Profile in Parkinson’s Disease: Insights from a Movement Disorders Center in Brazil

    F. Rolim, S. Lima, A. Verde, P. Matos, A. Marinho, F. Carvalho (Fortaleza, Brazil)

    Objective: To identify the prevalence of pathogenic variants of the GBA1 mutation among patients with parkinsonism who have undergone genetic testing. Background: GBA gene encodes…
  • 2024 International Congress

    The NINDS Approach to Therapeutic Development for Ultra-Rare Neurological Disorders, Bridging Translational and Clinical Frontiers in Gene-based Therapy

    HJ. Cho, A. Videnovic, M. Cudkowicz, C. Coffey, D. Klements, M. Chase, J. Ohayon, C. Boshoff, A. Tamiz, C. Wright (Rockville, USA)

    Objective: To establish an innovative process for fast and efficient pathways of delivering gene-based therapy for ultra-rare neurological disorders from the lab to the clinic…
  • 2024 International Congress

    SLC39A8-CDG with manganese deficiency in an adult individual: a case report

    D. Cury Portela, T. Gonçalves Guimarães, G. Sousa Noleto, L. Sousa Araújo, I. Paula, S. Morais, V. Santana Vasconcelos (Teresina, Brazil)

    Objective: To report the case of an adult male with SLC39A8-CDG and evaluate the effects of manganese supplementation on clinical evolution of the patient. Background:…
  • 2024 International Congress

    Understanding diffusion in extracellular space in synucleinopathy

    J. Estaún-Panzano, S. Nandi, Q. Gresil, C. Mazzocco, ML. Arotcarena, L. Cognet, E. Bezard (Bordeaux, France)

    Objective: To understand the extracellular space (ECS) diffusion in synucleinopathy. Background: The pathogenic mechanisms underlying synucleinopathies involve the spread and propagation of α-synuclein aggregates throughout…
  • 2024 International Congress

    Abnormal Subthalamic Oscillations as Potential Biomarkers for Identifying the Dyskinesia-Inducing Region within the Subthalamic Nucleus in Parkinson’s Disease

    J. Li, J. Wei, X. Jia, Y. Liang, Y. Zhang (beijing, China)

    Objective: To investigate the characteristics of local field potentials (LFPs) associated with the STN region that elicit stimulation-induced dyskinesia (SID) in PD patients. Background: Approximately 50%…
  • 2024 International Congress

    Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude

    B. Afsharipour, F. Roy, M. Schindle, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…
  • 2024 International Congress

    Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease

    S. Choudhury, P. Abhilash, P. Alladi (Bengaluru, India)

    Objective: To delineate the age-associated changes in microglial morphotypes in the substantia nigra pars compacta (SNpc) of C57BL/6J and CD-1 mice and alterations in response…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley